{"rows":[{"id":5982,"title":"From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy","authors":"Bélanger Gabriel, Chang Sue-Ling, Masse-Grenier Marianne, Tremblay Marie-Joëlle, Farzin Houman, Garel Nicolas, Dorval Michel","journal":"Drug Science, Policy and Law","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1177/20503245261494890","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.1177/20503245261494890","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article,Safety","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-10-08 01:20:19","last_checked":"2026-10-08 01:20:19","bibtex":null,"source_record_id":"DOI:10.1177/20503245261494890","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1177/20503245261494890","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1177/20503245261494890","source_url":"https://doi.org/10.1177/20503245261494890","doi":"10.1177/20503245261494890","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5974,"title":"Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.","authors":"Du X, Peng F, Wang X.","journal":"Molecular psychiatry","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1038/s41380-026-03918-4","pubmed_id":"42829371","openalex_id":null,"source_url":"https://doi.org/10.1038/s41380-026-03918-4","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Review Article,Safety","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-05 01:20:04","last_checked":"2026-10-08 01:20:20","bibtex":null,"source_record_id":"PMID:42829371","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41380-026-03918-4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42829371","source_url":"https://doi.org/10.1038/s41380-026-03918-4","doi":"10.1038/s41380-026-03918-4","pmid":"42829371","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5973,"title":"Serotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH.","authors":"Morena D, Lippi M, Biso L, Lucci F, Turillazzi E, Fineschi V, Scognamiglio P.","journal":"Clinical drug investigation","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1007/s40261-026-01599-z","pubmed_id":"42829418","openalex_id":"https://openalex.org/W7218417106","source_url":"https://doi.org/10.1007/s40261-026-01599-z","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity,Drug Interactions","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-05 01:20:04","last_checked":"2026-10-08 01:20:23","bibtex":null,"source_record_id":"PMID:42829418","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s40261-026-01599-z","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42829418","source_url":"https://doi.org/10.1007/s40261-026-01599-z","doi":"10.1007/s40261-026-01599-z","pmid":"42829418","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5962,"title":"Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies","authors":"Nadolski Bartosz, Poćwiardowski Wojciech, Łazarz Sonia, Gromniak-Haniecka Ewa","journal":"Pharmacotherapy in Psychiatry and Neurology","publication_date":"2026-09-29","publication_year":2026,"doi":"10.17219/fpn/237077","pubmed_id":null,"openalex_id":"https://openalex.org/W7214797486","source_url":"https://doi.org/10.17219/fpn/237077","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-09-30 01:20:19","last_checked":"2026-10-06 01:20:28","bibtex":null,"source_record_id":"DOI:10.17219/fpn/237077","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.17219/fpn/237077","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.17219/fpn/237077","source_url":"https://doi.org/10.17219/fpn/237077","doi":"10.17219/fpn/237077","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5955,"title":"Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study.","authors":"Eigenbrodt AK, Laigaard PP, Hassani M, Othman MH, Amiri M, Møller K, Kjaergaard J, Kondziella D","journal":"BMJ open","publication_date":"2026-09-22","publication_year":2026,"doi":"10.1136/bmjopen-2026-124508","pubmed_id":"42772877","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42772877/","substance_tags":"psilocybin","topic_tags":"Consciousness,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-09-24 01:20:06","last_checked":"2026-09-29 01:20:04","bibtex":null,"source_record_id":"PMID:42772877","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42772877/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42772877","source_url":"https://pubmed.ncbi.nlm.nih.gov/42772877/","doi":"10.1136/bmjopen-2026-124508","pmid":"42772877","publication_date":"2026-09-22","importer_version":"2.1.3","text_redistributed":false}},{"id":5950,"title":"Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling.","authors":"Abolhasani F, Rezaiezadeh H, Langarizadeh MA, Tavakoli MR, Ilaghi M, Zare P, Ravari FK, Alamdar F, Banazadeh M, Shabani M.","journal":"Mini reviews in medicinal chemistry","publication_date":"2026-09-18","publication_year":2026,"doi":"10.2174/0113895575443239260828094859","pubmed_id":"42770437","openalex_id":"https://openalex.org/W7213987315","source_url":"https://doi.org/10.2174/0113895575443239260828094859","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-23 01:20:07","last_checked":"2026-09-25 01:20:21","bibtex":null,"source_record_id":"PMID:42770437","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/0113895575443239260828094859","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42770437","source_url":"https://doi.org/10.2174/0113895575443239260828094859","doi":"10.2174/0113895575443239260828094859","pmid":"42770437","publication_date":"2026-09-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5948,"title":"EFFICACY AND SAFETY OF PSILOCYBIN IN TREATMENT-RESISTANT DEPRESSION: A REVIEW","authors":"Gawin Mateusz, Koziara Emilia, Gadzina Mateusz, Gawlak Julia, Krzesimir Kuświk Maciej, Tarnawska Zofia, Figiel Karolina, Sontag Wojciech, Zawisza Mateusz, Golec Aleksandra","journal":"International Journal of Innovative Technologies in Social Science","publication_date":"2026-09-21","publication_year":2026,"doi":"10.31435/ijitss.3(51).2026.6573","pubmed_id":null,"openalex_id":"https://openalex.org/W7213945218","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-09-22 01:20:19","last_checked":"2026-09-28 01:20:29","bibtex":null,"source_record_id":"DOI:10.31435/ijitss.3(51).2026.6573","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.31435/ijitss.3(51).2026.6573","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","doi":"10.31435/ijitss.3(51).2026.6573","pmid":"","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5947,"title":"A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults","authors":"Levy-Cooperman Naama, Sellers Edward, Glue Paul, Szeto Isabella, Brown David, Jarecki-Smith Jamie, Tyler William J., McDonnell Michael B.","journal":"Pharmaceuticals","publication_date":"2026-09-21","publication_year":2026,"doi":"10.3390/ph19091496","pubmed_id":"42797541","openalex_id":"https://openalex.org/W7213877811","source_url":"https://doi.org/10.3390/ph19091496","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-09-22 01:20:19","last_checked":"2026-09-28 01:20:29","bibtex":null,"source_record_id":"PMID:42797541","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/ph19091496","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42797541","source_url":"https://doi.org/10.3390/ph19091496","doi":"10.3390/ph19091496","pmid":"42797541","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5940,"title":"Comparative Policy Analysis of Psychedelic Therapy Regulation in Australia, Brazil, and the USA","authors":"A S Shikha, Jignesh Shah, Darshil B. Shah, Dilip Maheshwari","journal":"Applied Drug Research Clinical Trials and Regulatory Affairs","publication_date":"2026-09-14","publication_year":2026,"doi":"10.2174/0126673371488041260902064242","pubmed_id":null,"openalex_id":"https://openalex.org/W7213466340","source_url":"https://doi.org/10.2174/0126673371488041260902064242","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article,Safety,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-18 01:20:21","last_checked":"2026-09-21 01:20:28","bibtex":null,"source_record_id":"DOI:10.2174/0126673371488041260902064242","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.2174/0126673371488041260902064242","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.2174/0126673371488041260902064242","source_url":"https://doi.org/10.2174/0126673371488041260902064242","doi":"10.2174/0126673371488041260902064242","pmid":"","publication_date":"2026-09-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5934,"title":"Correlation of Ketamine and Classic Psychedelics with Pain-Related Neural Connectivity: A Scoping Review of Clinical Experiments on a Potential Therapeutic Target Concerning Ketamine and Classical Psychedelics Administration for Pain Relief","authors":"Vasileios Chytas, Georgios Tsimploulis, Dimitrios Chytas","journal":"Psychedelic Medicine","publication_date":"2026-09-14","publication_year":2026,"doi":"10.1177/28314425261489067","pubmed_id":null,"openalex_id":"https://openalex.org/W7212693934","source_url":"https://doi.org/10.1177/28314425261489067","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Review Article,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-16 01:20:19","last_checked":"2026-09-21 01:20:28","bibtex":null,"source_record_id":"DOI:10.1177/28314425261489067","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/28314425261489067","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/28314425261489067","source_url":"https://doi.org/10.1177/28314425261489067","doi":"10.1177/28314425261489067","pmid":"","publication_date":"2026-09-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5933,"title":"Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review","authors":"Civardi S, Besana F, Durbano F, Toscano M, Raffone F, Dell’Osso B, Olivola M.","journal":"Frontiers in psychiatry","publication_date":"2026-09-30","publication_year":2026,"doi":"10.3389/fpsyt.2026.1858319","pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC13621360","substance_tags":"psilocybin","topic_tags":"Depression,Review Article,Treatment-Resistant Depression","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-16 01:20:15","last_checked":"2026-10-03 01:20:25","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1858319","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://europepmc.org/article/PMC/PMC13621360","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.3389/fpsyt.2026.1858319","source_url":"https://europepmc.org/article/PMC/PMC13621360","doi":"10.3389/fpsyt.2026.1858319","pmid":"","publication_date":"2026-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5928,"title":"Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.","authors":"Raffa RB.","journal":"Cureus","publication_date":"2026-09-13","publication_year":2026,"doi":"10.7759/cureus.116178","pubmed_id":"42733721","openalex_id":"https://openalex.org/W7212432134","source_url":"https://doi.org/10.7759/cureus.116178","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Review Article,Treatment-Resistant Depression,Drug Interactions,Genomics","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-15 01:20:05","last_checked":"2026-09-20 01:20:21","bibtex":null,"source_record_id":"PMID:42733721","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.7759/cureus.116178","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42733721","source_url":"https://doi.org/10.7759/cureus.116178","doi":"10.7759/cureus.116178","pmid":"42733721","publication_date":"2026-09-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5924,"title":"Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review","authors":"Zhang Xizhen, Zhang Xiaowen, Zhang Haiyu, Wei Sheng","journal":"International Journal of Molecular Sciences","publication_date":"2026-09-10","publication_year":2026,"doi":"10.3390/ijms27188052","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3390/ijms27188052","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-09-13 01:20:11","last_checked":"2026-09-17 01:20:17","bibtex":null,"source_record_id":"DOI:10.3390/ijms27188052","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/ijms27188052","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/ijms27188052","source_url":"https://doi.org/10.3390/ijms27188052","doi":"10.3390/ijms27188052","pmid":"","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5923,"title":"Psilocybin and Chronic Neuropathic and Centralized Pain: Converging Mechanisms in Central Sensitization, Neuroplasticity, and Network Organization","authors":"Neves Marina Seixas Studart e, Gusmão Camilla Teixeira Pinheiro, Chiyo Raimundo, Manuel André Aloni João, Ulundo Avelino Hemenegildo, Jacinto Irina, Catumbela Azeres, João Vladimir Carlos Casimiro, Manuel Joel Armando, Pascoal Capela António, Montefusco-Pereira Carlos Victor, Ribeiro Junior Howard Lopes","journal":"Anesthesia Research","publication_date":"2026-09-11","publication_year":2026,"doi":"10.3390/anesthres3030026","pubmed_id":null,"openalex_id":"https://openalex.org/W7212279061","source_url":"https://doi.org/10.3390/anesthres3030026","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Meta-Analysis,Review Article,Case Report,Observational Study,Animal Study,Immune Function","study_type":"Meta-Analysis","source_name":"Crossref","publication_status":"published","date_added":"2026-09-13 01:20:11","last_checked":"2026-09-18 01:20:21","bibtex":null,"source_record_id":"DOI:10.3390/anesthres3030026","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/anesthres3030026","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/anesthres3030026","source_url":"https://doi.org/10.3390/anesthres3030026","doi":"10.3390/anesthres3030026","pmid":"","publication_date":"2026-09-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5922,"title":"Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System","authors":"Krantz MJ, Haigney MC, Southworth MR, Stockbridge N, Kao DP.","journal":"medRxiv","publication_date":"2026-09-10","publication_year":2026,"doi":"10.64898/2026.09.08.26362577","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.08.26362577","substance_tags":"psilocybin","topic_tags":"Addiction,Review Article,Safety,Adverse Events","study_type":"Review Article","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-12 01:20:56","last_checked":"2026-09-17 01:20:18","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.08.26362577","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.08.26362577","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.08.26362577","source_url":"https://doi.org/10.64898/2026.09.08.26362577","doi":"10.64898/2026.09.08.26362577","pmid":"","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5912,"title":"HORMONAL MODULATION OF PSILOCYBIN RESPONSIVITY ACROSS THE FEMALE REPRODUCTIVE LIFESPAN","authors":"Katarzyna Pawłucka, Aleksandra Pawlucka, Joanna Kadłuczka, Makary Hejduk, Magdalena Grzymek, Justyna Bury, Katarzyna Kraska, Jan Potoniec, Weronika Kępa, Aneta Sobek, Martyna Więcławek","journal":"International Journal of Innovative Technologies in Social Science","publication_date":"2026-08-31","publication_year":2026,"doi":"10.31435/ijitss.3(51).2026.6195","pubmed_id":null,"openalex_id":"https://openalex.org/W7208821196","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6195","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Longevity,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Cancer Patients,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-07 01:21:00","last_checked":"2026-09-07 01:21:00","bibtex":null,"source_record_id":"DOI:10.31435/ijitss.3(51).2026.6195","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6195","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.31435/ijitss.3(51).2026.6195","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6195","doi":"10.31435/ijitss.3(51).2026.6195","pmid":"","publication_date":"2026-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5909,"title":"Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives.","authors":"Vásquez-Bonilla JN.","journal":"Human psychopharmacology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/hup.70063","pubmed_id":"42693701","openalex_id":"https://openalex.org/W7208787084","source_url":"https://doi.org/10.1002/hup.70063","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article,Case Report,Animal Study,Safety,Drug Interactions,Inflammation,Immune Function","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-05 01:20:06","last_checked":"2026-09-08 01:20:16","bibtex":null,"source_record_id":"PMID:42693701","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1002/hup.70063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42693701","source_url":"https://doi.org/10.1002/hup.70063","doi":"10.1002/hup.70063","pmid":"42693701","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5908,"title":"A response to the letter to editor: Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy.","authors":"Khan FA, Pandupuspitasari NS, Tencomnao T, Chuchawankul S.","journal":"Journal of affective disorders","publication_date":"2026-09-02","publication_year":2026,"doi":"10.1016/j.jad.2026.122450","pubmed_id":"42686072","openalex_id":null,"source_url":"https://doi.org/10.1016/j.jad.2026.122450","substance_tags":"psilocybin","topic_tags":"Depression,Meta-Analysis,Systematic Review,Review Article","study_type":"Meta-Analysis","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-04 01:20:05","last_checked":"2026-09-09 01:20:55","bibtex":null,"source_record_id":"PMID:42686072","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42686072","source_url":"https://doi.org/10.1016/j.jad.2026.122450","doi":"10.1016/j.jad.2026.122450","pmid":"42686072","publication_date":"2026-09-02","importer_version":"2.1.3","text_redistributed":false}},{"id":5906,"title":"PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS","authors":"Anna Szeszko, Weronika Maria Czernek, Magdalena Cichorzewska, Martyna Płachta, Rafał Marcin Wojtan, Małgorzata Lubowiecka","journal":"International Journal of Innovative Technologies in Social Science","publication_date":"2026-08-31","publication_year":2026,"doi":"10.31435/ijitss.3(51).2026.6062","pubmed_id":null,"openalex_id":"https://openalex.org/W7204961421","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6062","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-03 01:20:16","last_checked":"2026-09-07 01:21:00","bibtex":null,"source_record_id":"DOI:10.31435/ijitss.3(51).2026.6062","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6062","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.31435/ijitss.3(51).2026.6062","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6062","doi":"10.31435/ijitss.3(51).2026.6062","pmid":"","publication_date":"2026-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5904,"title":"Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in Psychiatry","authors":"Damian Świeczkowski, Michał Pruc, Łukasz Szarpak, Aleksander Kwaśny, Wiesław Jerzy Cubała","journal":"Psychiatry International","publication_date":"2026-09-01","publication_year":2026,"doi":"10.3390/psychiatryint7050190","pubmed_id":null,"openalex_id":"https://openalex.org/W7204891799","source_url":"https://doi.org/10.3390/psychiatryint7050190","substance_tags":"psilocybin","topic_tags":"Depression,Chronic Pain,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety","study_type":"Systematic Review","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-03 01:20:15","last_checked":"2026-09-08 01:20:16","bibtex":null,"source_record_id":"DOI:10.3390/psychiatryint7050190","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychiatryint7050190","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychiatryint7050190","source_url":"https://doi.org/10.3390/psychiatryint7050190","doi":"10.3390/psychiatryint7050190","pmid":"","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}}],"total":1100,"page":1,"per_page":20,"pages":55,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Review Article","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}